Skip to main content

Table 1 Predicted HLA Class II Binding Alleles for the peptides used in this study

From: Profound tumor-specific Th2 bias in patients with malignant glioma

Epitope Predicted HLA Class II Binding Alleles
MAGE-A3112-127 DRB1*04, *08, *11, *13, DRB5*01
MAGE-A3121-136 DRB1*04, *07, *08, *11, *13, *15, DRB5*01
MAGE-A3143-160 DRB1*01, *03, *04, *07, *08, *11, *13, *15, DRB5*01
IL-13Ra2341-355 DRB1*01, *03, *04, *07, *08, *11, *13, *15, DRB5*01
IL-13Ra2351-365 DRB1*01, *03, *04, *07, *08, *11, *13, *15, DRB5*01
MBP85-99 DRB1*01, *03, *04, *08, *11, *13, *15
  1. Putative HLA-DR binding was determined using the ProPred MHC Class-II binding peptide prediction server, and emphasizes the promiscuous binding of the MAGE-A3 and IL-13Rα2 peptides used in this study.